Category: Insights

Driving Innovation: Drug Patents vs. Prizes

Joseph E Stiglitz, American economist and professor at Columbia University, states that prizes should be favored over patents to reward and stimulate innovation. The uniqueness of the patent system referred…
The post Driving Innovation: Drug Patents vs…


Review of Drug Repositioning Approaches and Resources

This paper was originally published by Hanqing Xue, Jie Li, Haozhe Xie, and Yadong Wang in Int J Biol Sci 2018; 14(10):1232-1244 under a Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). Abstract Drug…
T…


Measuring the effectiveness and impact of an open innovation platform

This paper was originally published by Glenn P. Carroll, Sanjay Srivastava, Adam S. Volini, Marta M. Piñeiro-Núñez, and TatianaVetman in Drug Discovery Today Volume 22, Issue 5, May 2017, Pages 776-785 under…
The post Measuring the effectiveness and im…


Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States

The story of Viagra’s patents and generic entry of sildenafil citrate is a valuable one because it covers many of the nuances of drug patenting and generic entry in the…
The post Viagra: A Complicated Case Study of Generic Drug Market Entry in the Unit…


Generic Drug Launch Dates – A 1-step Solution to Navigate the Web of Drug Patents and Regulatory Protections

Drugs can have many patents and regulatory protections Drugs can be covered by myriad patents and regulatory protections. Even Aspirin, which was first invented in 1853, has new patents. For…
The post Generic Drug Launch Dates – A 1-step Solution to Na…


Biosimilars in Developed and Developing East and Southeast Asian Countries: Japan, South Korea, and Malaysia—Overview, Evolution, and Regulations Assessment

This is paper was originally published in BioMed Research International, Volume 2016, by Tomas Gabriel Bas and Carolina Oliu Castillo under a Creative Commons Attribution License Abstract The development of…
The post Biosimilars in Developed and Develo…


China and Potential Opportunity for Pharmaceutical Investments

Although many areas of contention exist in trade relations between the United States and China, ties are strengthening between the two countries, particularly in the areas of science and technology.…
The post China and Potential Opportunity for Pharmac…


Evolving Pharmaceutical Strategies in a Post-Blockbuster World

Headlines about high drug prices are nothing new. The high cost of bringing new drugs to market, plus high merger and acquisition activity in pharmaceuticals have led to price increases…
The post Evolving Pharmaceutical Strategies in a Post-Blockbuster…


Balancing Opportunity and Risk in India’s Pharmaceutical Sector

India’s pharmaceutical industry has grown tremendously over the past thirty years and is now the world’s third largest drug producer as measured by volume. Hyderabad is one of India’s major…
The post Balancing Opportunity and Risk in India’s Pharmaceut…


Patents for Personalized Medicine: Challenges and Opportunities

Combination products are a key aspect of personalized medicine, offering more targeted treatment to patients The era of personalized medicine approaches more closely with each passing day, and with it…
The post Patents for Personalized Medicine: Challe…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: